Cannabinoid News and Research

Latest Cannabinoid News and Research

Prenatal cannabinoid use can cause behavioral and neuronal deficits in male offspring

Taking cannabinoids during pregnancy can cause behavioral and neuronal deficits in adult male offspring, while females remain unaffected, says new research published in eLife.

12 Sep 2018

Scientists shed light on how dangerous inflammations are caused in the brain

The so-called CB1 receptor is responsible for the intoxicating effect of cannabis. However, it appears to act also as a kind of “sensor” with which neurons measure and control the activity of certain immune cells in the brain.

31 Aug 2018

Clinical trials needed to inform doctors, parents on prescribing cannabinoids for Canadian children

Canadian parents use unregulated cannabinoids for seizure control in children with neurologic conditions like epilepsy, and clinical trials are needed to inform doctors and parents on prescribing, according to a commentary in CMAJ.

29 Aug 2018

NRGene partners with Pure Cannabis Research AG to develop novel cannabis varieties

NRGene, the leading provider of genome-wide sequencing and analysis, has partnered with Pure Cannabis Research AG, a Swiss breeding company that focuses on developing novel cannabis varieties. Pure Cannabis Research AG is a subsidiary of the Pure Holding AG.

22 Aug 2018

Study may fuel need for effective drug testing in hospital emergency departments

At a time when drug overdoses are becoming more prevalent and lethal, a new report provides a snapshot of regional illicit drug use and, for the first time, highlights the complexity of detecting and treating patients at hospital emergency departments for a severe drug-related event.

21 Aug 2018

Male tobacco smokers have decreased number of cannabinoid CB1 receptors, study reveals

Chronic, frequent tobacco smokers have a decreased number of cannabinoid CB1 receptors, the "pot receptor", when compared with non-smokers, reports a study in Biological Psychiatry.

15 Aug 2018

Long-term cannabinoid exposure impairs memory, study shows

A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor of Faculdade de Medicina of Universidade de Lisboa and her team in collaboration with researchers from the University of Lancaster, shows that the long-term use of either cannabis or cannabis-based drugs impairs memory.

13 Aug 2018

New DNA test predicts how humans may respond to cannabis

Today marks the launch of the Endocanna Health "Cannabinoid DNA Variant Test" the most comprehensive personalized cannabis DNA test available on the market today.

1 Aug 2018

Long-term use of cannabis or cannabis-based drugs can impair memory, shows study

Long-term use of either cannabis or cannabis-based drugs impairs memory say researchers. The study has implications for both recreational users and people who use the drug to combat epilepsy, multiple sclerosis and chronic pain.

23 Jul 2018

New review examines cannabinoids' potential for direct treatment of cancer

Previous research has shown that cannabinoids can help lessen side effects of anti-cancer therapies. Now a new British Journal of Pharmacology review has examined their potential for the direct treatment of cancer.

18 Jul 2018

Pre-clinical pilot study shows promising results of 'concussion pill'

In 2016, funded by a $16 million grant from Scythian, the multidisciplinary Miller School team embarked on a five-year study to examine the effects of combining CBD (a cannabinoid derivative of hemp) with an NMDA antagonist (an anesthetic used in animals and humans) for the treatment of traumatic brain injury and concussion.

16 Jul 2018

Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer

A class of molecules formed when the body metabolizes omega-3 fatty acids could inhibit cancer's growth and spread, University of Illinois researchers report in a new study in mice.

16 Jul 2018

Research sheds light on composition of cannabis used to treat children with epilepsy

A pioneering study has found Australian parents who turned to medicinal cannabis to treat children with epilepsy overwhelmingly (75 percent) considered the extracts as "effective". Contrary to parental expectations, extracts generally contained low doses of cannabidiol - commonly considered to be a key therapeutic element and that has been successfully used in recent clinical trials to treat epilepsy.

5 Jul 2018

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.

18 Jun 2018

Experts discuss how medicinal cannabis can impact opioid crisis

A multidisciplinary panel of experts discussed how medicinal cannabis can impact the opioid crisis, though clinical research to quantify this is difficult given strict federal laws

9 May 2018

Researchers find novel approach for in vivo real-time monitoring of metabolites

Real-time monitoring of the dynamics of endogenous molecules in organisms is an important aspect in the study of diseases.

2 May 2018

Study to examine whether cannabidiol provides therapeutic benefit to children with autism

Researchers at University of California San Diego School of Medicine are preparing a first-of-its-kind, multidisciplinary investigation to determine if and how cannabidiol, a non-psychoactive compound found in the cannabis plant, provides therapeutic benefit to children with severe symptoms of autism spectrum disorder.

27 Apr 2018

New review explores potentially safer therapies for treating chronic abdominal pain

An estimated 2 million people in the U.S. are addicted to prescription opioids- powerful doctor-prescribed medications for chronic or severe pain. The drugs are commonly prescribed to treat gastrointestinal pain caused by conditions such as Crohn's disease and irritable bowel syndrome (IBS), raising the risk of addiction among this population.

29 Mar 2018

Non-psychoactive cannabis ingredient could reduce risk of relapse among recovering addicts

A preclinical study in rats has shown that there might be value in using a non-psychoactive and non-addictive ingredient of the Cannabis sativa plant to reduce the risk of relapse among recovering drug and alcohol addicts.

23 Mar 2018

New study shows connection between coffee and cannabis

It's well known that a morning cup of joe jolts you awake. But scientists have discovered coffee affects your metabolism in dozens of other ways, including your metabolism of steroids and the neurotransmitters typically linked to cannabis, reports a new study from Northwestern Medicine.

15 Mar 2018

Cannabinoid News and Research

Latest Cannabinoid News and Research

Prenatal cannabinoid use can cause behavioral and neuronal deficits in male offspring

Scientists shed light on how dangerous inflammations are caused in the brain

Clinical trials needed to inform doctors, parents on prescribing cannabinoids for Canadian children

NRGene partners with Pure Cannabis Research AG to develop novel cannabis varieties

Study may fuel need for effective drug testing in hospital emergency departments

Male tobacco smokers have decreased number of cannabinoid CB1 receptors, study reveals

Long-term cannabinoid exposure impairs memory, study shows

New DNA test predicts how humans may respond to cannabis

Long-term use of cannabis or cannabis-based drugs can impair memory, shows study

New review examines cannabinoids' potential for direct treatment of cancer

Pre-clinical pilot study shows promising results of 'concussion pill'

Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer

Research sheds light on composition of cannabis used to treat children with epilepsy

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Experts discuss how medicinal cannabis can impact opioid crisis

Researchers find novel approach for in vivo real-time monitoring of metabolites

Study to examine whether cannabidiol provides therapeutic benefit to children with autism

New review explores potentially safer therapies for treating chronic abdominal pain

Non-psychoactive cannabis ingredient could reduce risk of relapse among recovering addicts

New study shows connection between coffee and cannabis

Pittcon Highlights: Cannabis & Psychedelics eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cannabinoid News and Research

Latest Cannabinoid News and Research

Pittcon Highlights: Cannabis & Psychedelics eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in